Filters
Other countries
Results: 1 to 20 of 20
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
HSPB3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Comprehensive Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 82 | 71 |
|
Distal Hereditary Motor Neuropathy Panel PreventionGenetics, part of Exact Sciences United States | 30 | 22 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Distal hereditary motor neuropathy type 2C (sequence analysis of HSPB3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Predominantly distal muscular atrophy Genologica Medica Spain | 43 | 18 |
|
Spinal muscular atrophy panel. 30-gene NGS panel. Genologica Medica Spain | 65 | 30 |
|
Neuronopathy, distal hereditary motor: Full gene sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Spinal Muscular Atrophy NGS Panel Fulgent Genetics United States | 93 | 29 |
|
Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation Athena Diagnostics Inc United States | 10 | 10 |
|
Spinal Muscular Atrophy (SMA) Panel CeGaT GmbH Germany | 44 | 27 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
Asper Biogene Asper Biogene LLC Estonia | 89 | 74 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Distal Hereditary Motor Neuronopathy, Type IIC MGZ Medical Genetics Center Germany | 1 | 1 |
|
Results: 1 to 20 of 20
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.